Lung function in very low birth weight infants after pharmacological and surgical treatment of patent ductus arteriosus - a retrospective analysis
Open Access
- 6 January 2017
- journal article
- research article
- Published by Springer Nature in BMC Pediatrics
- Vol. 17 (1) , 5
Abstract
The indications and strategies for treatment of patent ductus arteriosus (PDA) are controversial, and the safety and long-term benefits of surgical PDA closure remain uncertain. The aim of this study was to compare the lung function of very low birth weight (VLBW) infants after successful PDA treatment with a cyclooxygenase inhibitor or secondary surgical ligation. A total of 114 VLBW infants (birth weight < 1500 g), including 94 infants (82%) with a birth weight < 1000 g, who received treatment for hemodynamically significant PDA (hsPDA), were examined at a median postmenstrual age of 48 weeks. All infants were initially given pharmacological treatment, and 40 infants (35%) required PDA ligation. Lung function testing (LFT) included tidal breathing measurements, measurement of respiratory mechanics assessed by the occlusion test, whole-body plethysmography, SF6 multiple breath washout, forced expiratory flow (V’maxFRC) by the rapid thoracoabdominal compression technique, exhaled NO (FeNO), and arterialized capillary blood gas analysis. On the day of the LFT, the 2 groups had similar postconceptional age and body weight. However, the PDA ligation group was more immature at birth (p < 0.001) and had reduced respiratory compliance (p < 0.001), lower V’maxFRC (p = 0.006), increased airway resistance (Raw) (p < 0.001), and impaired blood gases (p < 0.001). Multivariate analysis showed that PDA surgery was an independent risk factor for increased Raw. PDA ligation after failed pharmacological treatment is associated with impaired lung function as compared to successful pharmacological closure in infants at a postmenstrual age of 48 weeks. However, only Raw was independently affected by PDA ligation, while all other differences were merely explained by patient characteristics.Keywords
This publication has 30 references indexed in Scilit:
- Recent Advances in the Treatment of Preterm Newborn Infants with Patent Ductus ArteriosusClinics in Perinatology, 2016
- A prospective study of maternal preference for indomethacin prophylaxis versus symptomatic treatment of a patent ductus arteriosus in preterm infantsBMC Pediatrics, 2015
- Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infantsCochrane Database of Systematic Reviews, 2015
- Ligation of the Patent Ductus Arteriosus in Preterm Infants: Understanding the PhysiologyThe Journal of Pediatrics, 2013
- Differential effects of immaturity and neonatal lung disease on the lung function of very low birth weight infants at 48-52 postconceptional weeksPediatric Pulmonology, 2013
- Lung Volume, Breathing Pattern and Ventilation Inhomogeneity in Preterm and Term InfantsPLOS ONE, 2009
- Neurosensory Impairment after Surgical Closure of Patent Ductus Arteriosus in Extremely Low Birth Weight Infants: Results from the Trial of Indomethacin Prophylaxis in PretermsThe Journal of Pediatrics, 2007
- Mechanics of Breathing after Surgical Ligation of Patent Ductus arteriosus in Newborns with Respiratory Distress SyndromeNeonatology, 2004
- Sex-Specific Prediction Equations for V˙maxFRC in Infancy: A Multicenter Collaborative StudyAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Improved lung compliance after ligation of patent ductus arteriosus in hyaline membrane diseaseThe Journal of Pediatrics, 1978